Back to Authors

Glazer, Craig S.

A5015537103 | I867280407

Mayo Clinic

The University of Texas Southwestern Medical Center

Citations 1

Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) Taking Anti-Acid Therapy

TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1906-A1906

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1906